MedTrace Logo

Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs

NCT00461253 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25565

Last updated 2016-01-25

Study results available
· View outcomes & findings →

Summary

The objective of this study is to determine the breast cancer risk of Mirena® users compared to copper intrauterine device (IUD) users in a community-based case-control study.

Conditions

Interventions

DEVICE

Levonorgestrel-releasing IUD

This is a case-control-study; strictly speaking the category "intervention type" does not apply to this study.

DEVICE

Copper IUD

This is a case-control-study; strictly speaking the category "intervention type" does not apply to this study.

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Center for Epidemiology and Health Research, Germany

    lead OTHER

Principal Investigators

  • Juergen Dinger, MD, PhD · Center for Epidemiology and Health Research

Eligibility

Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00461253 on ClinicalTrials.gov